Cognito Therapeutics is a BioTech company developing a neuromodulation medical device that aims to utilize non-invasive gamma-frequency sensory stimulation to improve the lives of patients with neurodegenerative diseases like Alzheimer's, Parkinson's, Multiple Sclerosis, and Ischemic Stroke. The company's stimulation therapy involves emitting specific frequencies of targeted light- and sound-based stimulations in an attempt to reset brainwaves and potentially slow cognitive decline.
